Innovation through Academic-Industry Partnerships in Clinical Trials
The University of Chicago Medicine performs more clinical trials than any other hospital in Illinois – translating ground-breaking innovations into life-changing therapeutics for patients in need.
Join UChicago Medicine on Clinical Trials Day – celebrated annually on May 20th – for a discussion about academic-industry partnerships.
“Clinical trials are the engine through which we translate innovative ideas to patient care reality. They are the lifeblood of an academic health system,” said Walter Stadler, Fred C. Buffett Professor of Medicine and dean for clinical research at the University of Chicago, who is moderating the panel discussion.
>> Register for the webinar: Innovation through Academic-Industry Partnerships in Clinical Trials
The panel from 12:00 p.m. to 1:00 p.m. (CST) will feature leading physician-researchers and life science executives who are driving medical innovation forward through clinical trial partnerships. Speakers include:
- Krishna Balakrishnan, deputy director, office of strategic alliances, National Center for Advancing Translational Sciences
- Ellen Bolotin, executive medical director, global development leader, AbbVie
- Hedy Kindler, professor of medicine, UChicago
- Olatoyosi Odenike, professor of medicine, UChicago
- David Rubin, Joseph B Kirsner Professor of Medicine, UChicago
- Sonali Smith, Elwood V. Jensen Professor of Medicine, UChicago
- Julian Solway, Walter L. Palmer Distinguished Service Professor of Medicine, dean for translational research
The discussion will explore three ways in which academic-industry clinical trial partnerships can take shape: Investigator-initiated clinical trials; industry-sponsored clinical trials; and licensing assets developed within universities to take through the clinical trial phases to market.
“The University of Chicago is a leader in medical research and innovation. Our clinical trial capabilities paired with the expertise of our faculty researchers and physicians make UChicago Medicine a great partner and location for clinical trials,” said Melissa Byrn, assistant dean for clinical research at the University.
UChicago Medicine has top-tier clinical capabilities, including a full suite of inpatient and outpatient clinical services, comprehensive biospecimen acquisition services, and on-site investigational drug service. It also provides virtual and remote monitoring capabilities as well as imaging and data services.
More than 350 clinical research staff support 1,000+ interventional trials currently active at UChicago Medicine, which has engaged over 30,000 patients in clinical research. The hospital has more than 300 industry partners, including 30 master clinical trial agreements.
// The webinar is co-sponsored by the University of Chicago Biological Sciences Division’s Office of Clinical Research, the Institute for Translational Medicine (ITM), and the Polsky Center for Entrepreneurship and Innovation at the University of Chicago.